|
Volumn 96, Issue 6, 2000, Pages 602-604
|
The STAR (Study of Tamoxifen and Raloxifene) trial in West Virginia.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
RALOXIFENE;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
TAMOXIFEN;
ADULT;
AGED;
ARTICLE;
BREAST TUMOR;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
FEMALE;
HUMAN;
MIDDLE AGED;
ORGANIZATION AND MANAGEMENT;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
UNITED STATES;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS, HORMONAL;
BREAST NEOPLASMS;
ELIGIBILITY DETERMINATION;
FEMALE;
HUMANS;
MIDDLE AGED;
QUALITY OF LIFE;
RALOXIFENE;
RANDOMIZED CONTROLLED TRIALS;
SELECTIVE ESTROGEN RECEPTOR MODULATORS;
TAMOXIFEN;
WEST VIRGINIA;
|
EID: 0034328936
PISSN: 00433284
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (9)
|
References (0)
|